Apimeds Pharmaceuticals US, Inc. (APUS)
1.390
-0.16
(-10.34%)
USD |
NYAM |
Feb 20, 16:00
1.36
-0.03
(-2.14%)
After-Hours: 20:00
Apimeds Pharmaceuticals US Shareholders Equity (Quarterly) : 8.161M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Imunon, Inc. | 4.082M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.25M |
| Total Liabilities (Quarterly) | 1.089M |
| Debt to Equity Ratio | 0.0613 |
| Current Ratio | 8.340 |
| Net Debt Paydown Yield | -0.09% |